A detailed history of Jane Street Group, LLC transactions in Biote Corp. stock. As of the latest transaction made, Jane Street Group, LLC holds 13,531 shares of BTMD stock, worth $70,496. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,531
Holding current value
$70,496
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$5.44 - $7.47 $73,608 - $101,076
13,531 New
13,531 $101,000
Q4 2023

Feb 14, 2024

BUY
$4.43 - $5.81 $13,577 - $17,807
3,065 Added 23.86%
15,910 $78,000
Q2 2023

Aug 14, 2023

BUY
$5.27 - $6.9 $67,693 - $88,630
12,845 New
12,845 $86,000

Others Institutions Holding BTMD

About biote Corp.


  • Ticker BTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 7,574,270
  • Market Cap $39.5M
  • Description
  • biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...
More about BTMD
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.